Special Issue "Cardiovascular Medicine: From Bench to Bedside"
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 8323
Cardiovascular disease (CVD) is a leading cause of deaths worldwide, with deaths due to atherothrombosis expected to increase yearly from 17.3 to 23.6 million by 2030. In the recent years, constant progresses in medical research, in parallel to the development of new techniques, have allowed better descriptions of the complex network of factors that are involved and cumulatively interact in the onset of the atherosclerotic phenomenon and in its progression. In this field, the improvement of omics approaches is helping to unravel the role of new and already known processes related to CVD development (e.g., oxidative stress, endothelial dysfunction, inflammation, fatty acid oxidation) beyond traditional risk factors. This is crucial for the development of innovative strategies in CVD prevention (including novel laboratory technologies to explore metabolic alterations and molecular studies of predisposition genes) and treatment. To identify appropriate targets in CVD prevention and treatment, the most advanced research information in the area field should be gathered and related or translated to practical (clinical and pathophysiological) questions. This is the aim and purpose of the present Special Issue of the journal.
Dr. Benedetta Porro
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cardiovascular disease
- oxidative stress
- endothelial dysfunction
- red blood cell
- circulating biomarker
- liquid chromatography-tandem mass spectrometry